Xtant medical holdings, inc. (XTNT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue
Orthopedic product sales

14,735

-

-

-

16,686

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Orthopedic product sales

-

-

15,691

15,197

-

18,192

17,139

18,653

17,830

-

19,618

21,371

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other revenue

43

22

30

74

40

70

127

88

104

-

171

37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Revenue

14,778

-

-

-

16,726

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Revenue

-

-

15,721

15,271

-

18,262

17,266

18,741

17,934

-

19,789

21,408

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,000

4,191

3,201

Orthopedic product sales

-

-

-

-

-

-

-

-

-

-

-

-

21,996

24,361

22,907

21,311

20,808

21,762

17,421

9,732

9,277

8,856

8,246

8,714

8,751

8,133

7,710

8,196

8,523

7,986

8,643

8,113

7,670

-

7,237

7,370

-

-

-

Other revenue

-

-

-

-

-

-

-

-

-

-

-

-

87

108

186

150

169

494

271

159

226

-

207

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalties and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

169

161

124

219

70

95

135

236

94

99

-80

302

138

131

146

15

Total Revenue

-

-

-

-

-

-

-

-

-

-

-

-

22,083

24,469

23,094

21,461

20,977

22,256

17,693

9,892

9,503

9,081

8,453

8,883

8,912

8,257

7,929

8,266

8,618

8,121

8,879

8,208

7,770

9,232

7,539

7,508

5,868

4,045

3,185

Cost of sales

5,165

5,639

5,249

5,365

5,913

11,006

5,743

6,266

5,702

9,039

8,416

7,880

7,176

6,960

7,114

6,758

6,877

7,379

6,035

3,375

3,472

3,315

3,017

3,290

3,410

4,174

3,318

3,572

3,120

3,548

2,600

2,329

1,858

-

1,318

1,742

-

-

-

Cost of tissue and medical devices sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

987

711

519

Gross Profit

9,613

11,325

10,472

9,906

10,813

7,256

11,523

12,475

12,232

10,293

11,373

13,528

14,907

17,509

15,980

14,703

14,100

14,877

11,657

6,517

6,030

5,766

5,435

5,593

5,502

4,083

4,611

4,694

5,498

4,573

6,279

5,878

5,911

4,039

6,220

5,766

5,013

3,480

2,682

Operating Expenses
General and administrative

4,319

5,263

4,155

4,041

4,477

4,633

3,121

3,498

3,025

3,261

3,330

4,527

4,128

4,605

3,773

3,899

3,484

4,188

3,980

2,399

2,425

2,221

2,282

2,093

2,288

2,819

2,726

2,086

2,572

3,785

2,439

2,319

2,590

888

2,149

1,505

2,391

2,128

1,940

Sales and marketing

6,413

6,347

6,682

6,072

6,742

6,723

7,847

8,545

8,349

9,473

8,904

11,137

10,997

11,879

11,242

10,420

10,512

10,551

8,430

5,035

4,713

4,525

3,927

4,405

4,055

3,959

4,053

4,205

3,798

4,283

3,352

3,835

4,146

5,096

4,809

4,331

4,264

2,320

1,683

Research and development

245

257

203

210

262

523

347

418

414

598

504

640

699

798

928

783

899

1,027

794

291

433

487

378

322

254

79

37

169

285

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

137

146

-

-

1,029

1,041

1,004

1,380

1,354

1,470

1,281

1,250

1,265

1,216

1,208

2,053

1,541

100

124

55

58

82

75

72

97

100

106

104

88

95

119

144

119

62

52

165

-

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-156

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,345

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of goodwill and intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

233

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition and integration related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

131

517

450

301

-

3,856

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring expenses

-

-

-

-

-

389

614

1,234

733

1,854

1,194

1,632

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Separation related expenses

-

-

-

-

-

-

-

-

-

504

792

381

224

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition and integration related expenses (Note 2)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash compensation expense

-

-

-

-

-

-

-

-

364

-132

-20

92

145

-

-

55

55

55

50

74

66

53

39

21

20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43

-0

-30

-63

186

-24

328

-

708

147

-

-

-

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

186

-24

328

-

708

147

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

151

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

240

951

182

Total Operating Expenses

10,977

11,642

11,177

10,469

11,481

61,981

12,958

14,736

13,889

34,524

16,058

19,879

17,474

18,665

17,883

16,825

16,462

18,955

16,542

7,900

7,763

8,256

6,686

6,925

6,694

7,643

6,959

6,561

6,731

8,109

6,066

6,226

7,184

6,708

7,786

6,046

6,949

5,565

3,959

Loss from Operations

-1,364

-317

-705

-563

-668

-54,725

-1,435

-2,261

-1,657

-24,231

-4,685

-6,351

-2,567

-1,156

-1,903

-2,122

-2,362

-4,077

-4,884

-1,383

-1,732

-2,490

-1,250

-1,332

-1,192

-3,559

-2,347

-1,866

-1,233

-3,536

212

-347

-1,273

-2,668

-1,565

-279

-1,936

-2,085

-1,277

Other (Expense) Income
Interest expense

1,108

1,268

1,185

1,301

2,018

1,990

1,790

2,820

3,545

4,168

3,809

3,328

3,400

3,287

3,163

2,984

2,827

2,802

2,111

1,383

1,435

1,444

1,498

1,441

1,275

1,217

1,197

1,174

1,063

560

867

266

170

116

541

132

372

160

782

Change in warrant derivative liability

6

10

4

4

-15

38

42

79

-38

67

-20

-14

170

0

220

477

18

348

397

-14

-462

697

1,653

870

-1,485

628

-849

460

635

-32

-125

1,301

217

-1,093

245

7

7,218

-6,731

7

Non-cash consideration associated with stock purchase agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

558

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other (expense) income

-5

1

30

-57

-75

-15

30

1

-13

-87

0

0

12

-41

-51

166

-425

581

-89

-114

11

-64

-70

3

-186

-15

17

98

-7

-42

-1,738

42

179

824

-1,302

0

6

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

65

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total Other (Expense)

-1,107

-1,257

-1,151

-1,354

-2,108

-1,966

-1,718

-2,741

-3,596

-4,188

-3,829

-3,342

-3,218

-3,329

-2,994

-2,340

-3,233

-1,872

-1,804

-1,512

-2,444

-811

84

-568

-2,948

-604

-2,029

-616

-435

-1,341

-2,732

1,077

226

-1,685

-1,598

-125

6,853

-6,958

-773

Net Loss Before Provision for Income Taxes

-2,471

-1,574

-1,856

-1,917

-2,776

-56,691

-3,153

-5,002

-5,253

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,878

-2,519

730

-1,046

-

-3,164

-405

-

-

-

Provision for Income Taxes
Net Loss Before (Provision) Benefit for Income Taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,916

-9,043

-2,051

Current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

Deferred

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

Provision for income taxes

22

-166

23

22

23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-2,493

-1,604

-1,879

-1,939

-2,799

-56,691

-3,153

-5,002

-5,253

-28,419

-8,514

-9,693

-5,785

-4,536

-4,898

-4,462

-5,596

11,587

-6,688

-2,895

-4,176

-3,301

-1,165

-1,900

-4,140

-4,164

-4,376

-2,483

-1,669

-4,878

-2,519

730

-1,046

-4,353

-3,164

-405

4,916

-9,043

-2,051

Net loss per share:
Basic

-0.19

-0.13

-0.14

-0.15

-0.21

-4.65

-0.24

-0.38

-0.70

-18.84

-5.62

-6.43

-3.87

-17.22

-0.40

-0.37

-0.47

1.43

-0.64

-0.41

-0.62

-0.45

-0.19

-0.35

-0.77

-1.36

-0.85

-0.55

-0.04

-0.11

-0.06

0.02

-0.03

-0.12

-0.08

-0.01

0.13

-0.26

-0.07

Dilutive

-0.19

-0.13

-0.14

-0.15

-0.21

-4.65

-0.24

-0.38

-0.70

-18.84

-5.62

-6.43

-3.87

-17.22

-0.40

-0.37

-0.47

1.43

-0.64

-0.41

-0.62

-0.45

-0.19

-0.35

-0.77

-1.36

-0.85

-0.55

-0.04

-0.11

-0.06

0.02

-0.03

-0.10

-0.08

-0.01

0.11

-0.26

-0.07

Shares used in the computation:
Basic

13,175

13,161

13,161

13,161

13,170

13,236

13,158

13,085

7,481

1,514

1,514

1,507

1,494

-31,969

12,193

12,101

11,897

11,962

10,432

7,137

6,689

6,688

6,233

5,514

5,379

-34,492

5,161

4,525

42,926

42,741

42,796

42,695

41,548

40,654

39,574

38,216

37,330

35,398

28,318

Dilutive

13,175

13,161

13,161

13,161

13,170

13,236

13,158

13,085

7,481

1,514

1,514

1,507

1,494

-31,969

12,193

12,101

11,897

11,962

10,432

7,137

6,689

6,688

6,233

5,514

5,379

-34,492

5,161

4,525

42,926

40,753

42,796

44,683

41,548

33,565

39,574

38,216

44,419

35,398

28,318